Semen Analysis After Proton Therapy for Prostate Cancer (PR08)

University of Florida

Status: Completed

Conditions: Prostate Cancer

Treatments: Other: Semen analysis

Study type: Interventional

Funder types: Other

Identifiers

NCT01072513

UFPTI-0908-PR08

Details and patient eligibility

About

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

Enrollment: 31 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

Exclusion criteria

• Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
• History of vasectomy.
• Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
• Current use of Avodart or Proscar.

Trial design

31 participants in 1 patient group

Semen analysis

Other group

Description:

Analysis of semen before and after proton radiation therapy.

Treatment:

Other: Semen analysis